Tibremciclib is a selective inhibitor of cyclin-dependent kinase 4 (CDK4), exhibiting significant antineoplastic activity. By blocking CDK4 activity, it disrupts cell cycle progression and promotes apoptosis in cancer cells. Tibremciclib is primarily utilized in cancer research and therapeutic applications, focusing on targeting tumors driven by aberrant CDK4 signaling.
Tibremciclib is a selective inhibitor of cyclin-dependent kinase 4 (CDK4), exhibiting significant antineoplastic activity. By blocking CDK4 activity, it disrupts cell cycle progression and promotes apoptosis in cancer cells. Tibremciclib is primarily utilized in cancer research and therapeutic applications, focusing on targeting tumors driven by aberrant CDK4 signaling.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
